The prevalence of hypertension ranged between 30.2% (Yeh et al., 2020, in people with early-onset AD) (94) and 73.8%/73.9% (Xu et al., 2021, in acetylcholinesterase inhibitor users and non-users, respectively) (60). This evidence concerns the gene ACHE and hypertensive disorder.